Nucleix’s New Assay May Differentiate Small Cell Lung Cancer Subtypes
Nucleix will present data that demonstrates the potential of a PCR assay to accurately differentiate between small cell lung cancer subtypes.
Read MorePosted by Andy Lundin | Apr 4, 2024 | Lung Cancer |
Nucleix will present data that demonstrates the potential of a PCR assay to accurately differentiate between small cell lung cancer subtypes.
Read MorePosted by Andy Lundin | Apr 4, 2024 | Breast |
This collaborative study seeks to represent a significant step forward in digital pathology and oncology breast cancer research
Read MorePosted by Andy Lundin | Mar 25, 2024 | Unknown Origin & Other Cancer Types |
The tumor cell enumeration assay is a diagnostic test that is promising for establishing the diagnosis of leptomeningeal metastases.
Read MorePosted by Andy Lundin | Mar 21, 2024 | Lung Cancer |
The test guides first-line treatment selection by identifying individuals with the highest likelihood of benefit from PD-1/PD-L1 inhibitors
Read MorePosted by Andy Lundin | Feb 22, 2024 | Diagnostic Technologies |
A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis.
Read More